市場調査レポート

商品コード

オルガノイドサービスの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、用途別、供給源別、地域別

Organoids Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, and Geography

出版日: 2024年08月27日
発行: The Insight Partners
ページ情報: 英文 168 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 643,648円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 932,928円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,222,208円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

オルガノイドサービス市場は2023年の30億3,000万米ドルから成長し、2031年には150億1,000万米ドルに達すると予測され、2023年から2031年にかけて22.3％のCAGRを記録すると予測されています。オルガノイドサービス市場の成長要因には、新規薬剤スクリーニングサービスに対する需要の高まりや、オーダーメイド薬剤の人気の高まりなどがあります。しかし、熟練した専門家の不足や厳しい安全規制が市場成長の妨げとなっています。

オルガノイドは、単純な組織工学的細胞ベースのin vitroモデルであり、対応するin vivo組織の複雑な構造と機能の多くの側面を再現します。また、診断、疾患モデル、創薬、個別化医療にも利用できます。

北米がオルガノイドサービス市場を独占しています。米国の市場プレーヤーは、足場を固めるために有機的成長戦略に注力しています。2023年2月、Molecular Devices, LLC.とHUB Organoids（HUB）は、前臨床から臨床への薬剤減少を段階的に減少させる次世代3D生物学技術の開発を継続する戦略的提携を発表しました。さらに、研究開発活動の増加、組織工学と臓器移植の需要の高まり、オルガノイドの高い導入率が、国内のオルガノイドサービス市場を牽引しています。オルガノイドは、生物医学研究に関連するこれまでのいくつかの制限を克服する可能性を秘めており、研究者がヒトの発生に関するメカニズム的洞察を利用できるようにすること、ヒト疾患の正確なモデルを作成すること、再生医療のために患者に適合した組織ソースを生成することに高い関心が寄せられています。アジア太平洋地域は、2023年から2031年にかけて最も高いCAGRを記録すると予測されています。

新興国市場の主な発展が今後の市場機会をもたらす

ヘルスケアの進展により、オルガノイドの需要は世界中で増加しています。この需要増加は、世界レベルでの新製品開発、買収、提携、製品発売、承認に寄与しています。主要な市場関係者は、効率的なサービスと製品の革新と開拓を確実にするための活動に取り組んでいます。最近の主な動向をいくつか以下に示す：

2024年6月、Molecular Devices, LLC.は英国のカーディフに専用施設を正式に開設しました。数百万ポンドを投じたこの施設は、同社独自のバイオプロセスワークフローと革新的なバイオリアクター技術に対応するよう設計され、PDOの大規模かつ品質管理された生産を可能にしました。3D対応の再現性の高いPDOをカスタムサービスとして大量に提供し、分析に適した形で凍結保存することができます。研究者は必要に応じてこれらの製品を解凍、プレート化し、使用することができます。

2024年5月、バイオテクノロジー企業のInSphero社は、フランクフルトのGenome Biologics社とパートナーシップ契約を締結しました。この提携により、InSphero社はGenome Biologics社の3D心臓オルガノイド・プラットフォームを商品化する独占的世界権を獲得します。このプラットフォームは、新しい治療法を生み出すための正確でスケーラブルな疾患特異的オルガノイドモデルを提供し、心臓病研究の最前線に位置します。

2023年7月、モレキュラー・デバイスは、ハイスループット・アプリケーションのための独自のバイオプロセス技術を用いたカスタム・オルガノイド・ライン拡張サービスを開始しました。

2023年2月、Molecular Devices, LLC.とHUB Organoids（HUB）は戦略的提携を発表し、前臨床から臨床への薬剤減少を段階的に減少させる次世代3D生物学技術の継続的開発に貢献します。

2022年12月、Molecular Devices, LLC.はCellesce Ltd.を買収しました。この買収は、受託開発および製造サービスを通じて、薬剤スクリーニングを含む様々な目的のための大規模PDOの製造に焦点を当てています。

2021年8月、STEMCELL TechnologiesとHubrecht Organoid Technology（HUB）は契約を締結しました。この契約の一環として、STEMCELLのコントラクトアッセイサービス部門は、肺、腸、肝臓オルガノイドなどの組織由来オルガノイドを、前臨床毒性学スクリーニングや非がん薬開発サービスのためにHUBに提供し始めました。これらのサービスは、研究者や医薬品開発組織による前臨床試験プログラムへのオルガノイドの統合を促進し、新治療法の迅速かつ経済的な上市を支援するものです。

このような主な発展、市場参入、市場企業間の戦略的提携は、オルガノイドサービス市場の成長にとって十分な機会を創出します。

用途別洞察

用途別では、発生生物学、感染症病理学、再生医療、薬剤毒性・有効性試験、創薬・個別化医療、その他に区分されます。発生生物学疾患分野は2023年に市場で最大のシェアを占め、さらに2023年から2031年にかけて最も高いCAGRを記録すると予測されています。

供給源に基づく洞察

オルガノイドサービス市場は、供給源に基づき、多能性幹細胞と臓器特異的成体幹細胞に分けられます。2023年の市場では、多能性幹細胞分野が大きなシェアを占めています。多能性幹細胞セグメントは予測期間中に高いCAGRを記録すると予測されています。

オルガノイドサービス市場競合情勢と主な発展

Sino Biological Inc.、Eurofins Scientific SE、Molecular Devices, LLC.、InSphero、Cyprio、InnoSer、LABTOO、CUSABIO TECHNOLOGY LLC、Oncodesign Services、HUB Organoids B.V.（Hubrecht Organoid Technology）などが、オルガノイドサービス市場で事業を展開する主要企業です。

米国食品医薬品局、米国疾病管理予防センター（CDC）、世界疾病負担調査（Global Burden of Disease Study）などは、オルガノイドサービス市場レポート作成時に参照した一次情報および二次情報です。

有機臓器サービス市場- 主要市場力学
市場促進要因
- 革新的な薬物スクリーニングサービスに対する需要の増加
- 個別化医薬品の急増
市場抑制要因
- 熟練専門家の不足
市場機会
- 主な発展の増加
今後の動向
- 人工知能の統合
促進要因と抑制要因の影響

第6章オルガノイドサービス市場：世界市場分析

オルガノイドサービスの市場収益、2021年～2031年
オルガノイドサービス市場予測分析

第7章オルガノイドサービス市場分析：タイプ別

腸
肝臓
胃
膵臓
肺
脳
腎臓
その他

第8章オルガノイドサービス市場分析：用途別

発生生物学疾患
感染症病理
再生医療
医薬品の毒性・有効性試験
創薬および個別化医療
その他

第9章オルガノイドサービス市場分析：供給源別

多能性幹細胞
臓器特異的成体幹細胞

第10章オルガノイドサービス市場：地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- APACのその他諸国
中東・アフリカ
- サウジアラビア
- 南アフリカ
- アラブ首長国連邦
- その他中東とアフリカ
中南米
- ブラジル
- アルゼンチン
- その他中南米

第11章業界情勢

オルガノイドサービス市場における成長戦略
有機的成長戦略
無機的成長戦略
- 成長戦略

第12章企業プロファイル

Sino Biological Inc.
Eurofins Scientific SE
Molecular Devices, LLC.
InSphero
Cyprio
InnoSer
LABTOO
CUSABIO TECHNOLOGY LLC
Oncodesign Services
HUB Organoids B.V.（Hubrecht Organoid Technology）

第13章付録

図表

List Of Tables

Table 1. Organoids Services Market Segmentation
Table 2. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Source
Table 6. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 7. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 8. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 9. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 10. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 11. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 12. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 13. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 14. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 16. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 17. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 19. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 20. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 21. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 22. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 23. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 24. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 25. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 26. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 27. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 28. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 29. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 30. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 31. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 32. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 34. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 35. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 36. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 37. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 38. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 39. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 40. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 41. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 42. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 43. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 44. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 45. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 46. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 47. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 48. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 49. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 50. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 51. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 52. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 53. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 54. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 55. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 57. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 58. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 59. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 60. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 61. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 62. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 63. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 64. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 65. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 66. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 67. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 68. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 69. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 70. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 71. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 72. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 73. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 74. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 75. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 76. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 77. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 78. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 79. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 80. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 81. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 82. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 83. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 84. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 85. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 86. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 87. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 88. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 89. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 90. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 91. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
Table 92. Recent Organic Growth Strategies in Organoids Services Market
Table 93. Recent Inorganic Growth Strategies in the Organoids Services Market
Table 94. Glossary of Terms, Organoids Services Market

List Of Figures

Figure 1. Organoids Services Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organoids Services Market Revenue (US$ Million), 2021-2031
Figure 5. Organoids Services Market Share (%) - by Type (2023 and 2031)
Figure 6. Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Organoids Services Market Share (%) - by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Organoids Services Market Share (%) - by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Organoids Services Market Breakdown by Region, 2023 and 2031 (%)
Figure 25. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. North America: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 27. North America: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 28. North America: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 29. North America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 32. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 35. Europe: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 36. Europe: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 37. Europe: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 38. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 45. Asia Pacific: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 46. Asia Pacific: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 47. Asia Pacific: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 48. Asia Pacific: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 50. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 51. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 54. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 55. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 56. Middle East and Africa: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 57. Middle East and Africa: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 58. Middle East and Africa: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 59. Middle East and Africa: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 60. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 61. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 62. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 63. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 64. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 65. South and Central America: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 66. South and Central America: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 67. South and Central America: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 68. South and Central America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 69. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 70. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 71. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
Figure 72. Growth Strategies in Organoids Services Market

Product Code: TIPRE00039302

According to our new research study on "Organoids Services Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.3% during 2023-2031. Factors contributing to the organoids services market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.

Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.

North America dominates the organoids services market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.

Increasing Key Developments to Provide Market Opportunities in Future

The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:

In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.

In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.

In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.

In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.

In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.

In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.

Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth..

Application -Based Insights

By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.

Source -Based Insights

Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.

Organoids services Market: Competitive Landscape and Key Developments

Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids services market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids services market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Organoids Services Market Landscape

4.1 PEST Analysis

5. Organoids Services Market - Key Market Dynamics

5.1 Organoids Services Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Demand for Innovative Drug Screening Services
- 5.2.2 Surge in Popularity of Personalized Drugs
5.3 Market Restraints
- 5.3.1 Dearth of Skilled Professionals
5.4 Market Opportunities
- 5.4.1 Increasing Key Developments
5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence
5.6 Impact of Drivers and Restraints:

6. Organoids Services Market - Global Market Analysis

6.1 Organoids Services Market Revenue (US$ Million), 2021-2031
6.2 Organoids Services Market Forecast Analysis

7. Organoids Services Market Analysis - by Type

7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Services Market Analysis - by Application

8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Services Market Analysis - by Source

9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Services Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Organoids Services Market Overview
- 10.2.2 North America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.3 North America: Organoids Services Market Breakdown, by Type
  - 10.2.3.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.2.4 North America: Organoids Services Market Breakdown, by Application
  - 10.2.4.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.2.5 North America: Organoids Services Market Breakdown, by Source
  - 10.2.5.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.2.6 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.2.6.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.2.6.2 United States: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.6.2.1 United States: Organoids Services Market Breakdown, by Type
    - 10.2.6.2.2 United States: Organoids Services Market Breakdown, by Application
    - 10.2.6.2.3 United States: Organoids Services Market Breakdown, by Source
  - 10.2.6.3 Canada: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.6.3.1 Canada: Organoids Services Market Breakdown, by Type
    - 10.2.6.3.2 Canada: Organoids Services Market Breakdown, by Application
    - 10.2.6.3.3 Canada: Organoids Services Market Breakdown, by Source
  - 10.2.6.4 Mexico: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.6.4.1 Mexico: Organoids Services Market Breakdown, by Type
    - 10.2.6.4.2 Mexico: Organoids Services Market Breakdown, by Application
    - 10.2.6.4.3 Mexico: Organoids Services Market Breakdown, by Source
10.3 Europe
- 10.3.1 Europe Organoids Services Market Overview
- 10.3.2 Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.3 Europe: Organoids Services Market Breakdown, by Type
  - 10.3.3.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.3.4 Europe: Organoids Services Market Breakdown, by Application
  - 10.3.4.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.3.5 Europe: Organoids Services Market Breakdown, by Source
  - 10.3.5.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.3.6 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.3.6.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.3.6.2 Germany: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.2.1 Germany: Organoids Services Market Breakdown, by Type
    - 10.3.6.2.2 Germany: Organoids Services Market Breakdown, by Application
    - 10.3.6.2.3 Germany: Organoids Services Market Breakdown, by Source
  - 10.3.6.3 United Kingdom: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.3.1 United Kingdom: Organoids Services Market Breakdown, by Type
    - 10.3.6.3.2 United Kingdom: Organoids Services Market Breakdown, by Application
    - 10.3.6.3.3 United Kingdom: Organoids Services Market Breakdown, by Source
  - 10.3.6.4 France: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.4.1 France: Organoids Services Market Breakdown, by Type
    - 10.3.6.4.2 France: Organoids Services Market Breakdown, by Application
    - 10.3.6.4.3 France: Organoids Services Market Breakdown, by Source
  - 10.3.6.5 Italy: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.5.1 Italy: Organoids Services Market Breakdown, by Type
    - 10.3.6.5.2 Italy: Organoids Services Market Breakdown, by Application
    - 10.3.6.5.3 Italy: Organoids Services Market Breakdown, by Source
  - 10.3.6.6 Spain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.6.1 Spain: Organoids Services Market Breakdown, by Type
    - 10.3.6.6.2 Spain: Organoids Services Market Breakdown, by Application
    - 10.3.6.6.3 Spain: Organoids Services Market Breakdown, by Source
  - 10.3.6.7 Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.6.7.1 Rest of Europe: Organoids Services Market Breakdown, by Type
    - 10.3.6.7.2 Rest of Europe: Organoids Services Market Breakdown, by Application
    - 10.3.6.7.3 Rest of Europe: Organoids Services Market Breakdown, by Source
10.4 Asia Pacific
- 10.4.1 Asia Pacific Organoids Services Market Overview
- 10.4.2 Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.3 Asia Pacific: Organoids Services Market Breakdown, by Type
  - 10.4.3.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.4.4 Asia Pacific: Organoids Services Market Breakdown, by Application
  - 10.4.4.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.4.5 Asia Pacific: Organoids Services Market Breakdown, by Source
  - 10.4.5.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.4.6 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.4.6.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.4.6.2 Japan: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.2.1 Japan: Organoids Services Market Breakdown, by Type
    - 10.4.6.2.2 Japan: Organoids Services Market Breakdown, by Application
    - 10.4.6.2.3 Japan: Organoids Services Market Breakdown, by Source
  - 10.4.6.3 China: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.3.1 China: Organoids Services Market Breakdown, by Type
    - 10.4.6.3.2 China: Organoids Services Market Breakdown, by Application
    - 10.4.6.3.3 China: Organoids Services Market Breakdown, by Source
  - 10.4.6.4 India: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.4.1 India: Organoids Services Market Breakdown, by Type
    - 10.4.6.4.2 India: Organoids Services Market Breakdown, by Application
    - 10.4.6.4.3 India: Organoids Services Market Breakdown, by Source
  - 10.4.6.5 South Korea: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.5.1 South Korea: Organoids Services Market Breakdown, by Type
    - 10.4.6.5.2 South Korea: Organoids Services Market Breakdown, by Application
    - 10.4.6.5.3 South Korea: Organoids Services Market Breakdown, by Source
  - 10.4.6.6 Australia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.6.1 Australia: Organoids Services Market Breakdown, by Type
    - 10.4.6.6.2 Australia: Organoids Services Market Breakdown, by Application
    - 10.4.6.6.3 Australia: Organoids Services Market Breakdown, by Source
  - 10.4.6.7 Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.6.7.1 Rest of APAC: Organoids Services Market Breakdown, by Type
    - 10.4.6.7.2 Rest of APAC: Organoids Services Market Breakdown, by Application
    - 10.4.6.7.3 Rest of APAC: Organoids Services Market Breakdown, by Source
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Organoids Services Market Overview
- 10.5.2 Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 Middle East and Africa: Organoids Services Market Breakdown, by Type
  - 10.5.3.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.5.4 Middle East and Africa: Organoids Services Market Breakdown, by Application
  - 10.5.4.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.5.5 Middle East and Africa: Organoids Services Market Breakdown, by Source
  - 10.5.5.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.5.6 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.5.6.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.5.6.2 Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.2.1 Saudi Arabia: Organoids Services Market Breakdown, by Type
    - 10.5.6.2.2 Saudi Arabia: Organoids Services Market Breakdown, by Application
    - 10.5.6.2.3 Saudi Arabia: Organoids Services Market Breakdown, by Source
  - 10.5.6.3 South Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.3.1 South Africa: Organoids Services Market Breakdown, by Type
    - 10.5.6.3.2 South Africa: Organoids Services Market Breakdown, by Application
    - 10.5.6.3.3 South Africa: Organoids Services Market Breakdown, by Source
  - 10.5.6.4 United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.4.1 United Arab Emirates: Organoids Services Market Breakdown, by Type
    - 10.5.6.4.2 United Arab Emirates: Organoids Services Market Breakdown, by Application
    - 10.5.6.4.3 United Arab Emirates: Organoids Services Market Breakdown, by Source
  - 10.5.6.5 Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.6.5.1 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Type
    - 10.5.6.5.2 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Application
    - 10.5.6.5.3 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Source
10.6 South and Central America
- 10.6.1 South and Central America Organoids Services Market Overview
- 10.6.2 South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.3 South and Central America: Organoids Services Market Breakdown, by Type
  - 10.6.3.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.6.4 South and Central America: Organoids Services Market Breakdown, by Application
  - 10.6.4.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.6.5 South and Central America: Organoids Services Market Breakdown, by Source
  - 10.6.5.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.6.6 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.6.6.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
  - 10.6.6.2 Brazil: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.6.2.1 Brazil: Organoids Services Market Breakdown, by Type
    - 10.6.6.2.2 Brazil: Organoids Services Market Breakdown, by Application
    - 10.6.6.2.3 Brazil: Organoids Services Market Breakdown, by Source
  - 10.6.6.3 Argentina: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.6.3.1 Argentina: Organoids Services Market Breakdown, by Type
    - 10.6.6.3.2 Argentina: Organoids Services Market Breakdown, by Application
    - 10.6.6.3.3 Argentina: Organoids Services Market Breakdown, by Source
  - 10.6.6.4 Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.6.4.1 Rest of South and Central America: Organoids Services Market Breakdown, by Type
    - 10.6.6.4.2 Rest of South and Central America: Organoids Services Market Breakdown, by Application
    - 10.6.6.4.3 Rest of South and Central America: Organoids Services Market Breakdown, by Source

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organoids Services Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Sino Biological Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Eurofins Scientific SE
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Molecular Devices, LLC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 InSphero
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Cyprio
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 InnoSer
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 LABTOO
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 CUSABIO TECHNOLOGY LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Oncodesign Services
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

オルガノイドサービスの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、用途別、供給源別、地域別

Organoids Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章オルガノイドサービス市場情勢

第5章オルガノイドサービス市場：主要市場力学

第6章オルガノイドサービス市場：世界市場分析

第7章オルガノイドサービス市場分析：タイプ別

第8章オルガノイドサービス市場分析：用途別

第9章オルガノイドサービス市場分析：供給源別

第10章オルガノイドサービス市場：地域別分析

第11章業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Organoids Services Market Landscape

5. Organoids Services Market - Key Market Dynamics

6. Organoids Services Market - Global Market Analysis

7. Organoids Services Market Analysis - by Type

8. Organoids Services Market Analysis - by Application

9. Organoids Services Market Analysis - by Source

10. Organoids Services Market - Geographical Analysis

11. Industry Landscape

12. Company Profiles

13. Appendix

オルガノイドサービスの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、用途別、供給源別、地域別

Organoids Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 オルガノイドサービス市場情勢

第5章 オルガノイドサービス市場：主要市場力学

第6章 オルガノイドサービス市場：世界市場分析

第7章 オルガノイドサービス市場分析：タイプ別

第8章 オルガノイドサービス市場分析：用途別

第9章 オルガノイドサービス市場分析：供給源別

第10章 オルガノイドサービス市場：地域別分析

第11章 業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Organoids Services Market Landscape

5. Organoids Services Market - Key Market Dynamics

6. Organoids Services Market - Global Market Analysis

7. Organoids Services Market Analysis - by Type

8. Organoids Services Market Analysis - by Application

9. Organoids Services Market Analysis - by Source

10. Organoids Services Market - Geographical Analysis

11. Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章オルガノイドサービス市場情勢

第5章オルガノイドサービス市場：主要市場力学

第6章オルガノイドサービス市場：世界市場分析

第7章オルガノイドサービス市場分析：タイプ別

第8章オルガノイドサービス市場分析：用途別

第9章オルガノイドサービス市場分析：供給源別

第10章オルガノイドサービス市場：地域別分析

第11章業界情勢

第12章企業プロファイル

第13章付録